IMRX
#3389
Immuneering Corporation - Class A Common Stock
3.8 6 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.03%
Monthly Change
-9.81%
6 month change
-32.87%
Year Change
-36.51%
Previous Close
3.9 4
Open
3.9 4
Low
3.8 1
High
3.9 5
Financials
- Market Capitalization 249.73 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.18
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3371 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 2.83 USD | -5.03% | -9.29% | -17.25% | +23.58% | 257.49 M USD | ||
| 3380 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -2.29% | -12.70% | -7.39% | +54.35% | 255.22 M USD | ||
| 3391 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 3.04 USD | -5.88% | -11.37% | -29.47% | -62.33% | 249.42 M USD | ||
| 3392 |  ACIU AC Immune SA - Common Stock | 2.45 USD | -2.00% | -9.93% | -10.26% | -28.57% | 249.27 M USD |
Frequently asked questions about Immuneering Corporation Class A Common Stock
What is the Immuneering Corporation Class A Common Stock stock price today?
The current price of Immuneering Corporation Class A Common Stock (IMRX) is 3.86. Over the past 24 hours, the stock has changed by -2.03%. Follow the IMRX chart for real-time price dynamics.
What is the stock ticker of Immuneering Corporation Class A Common Stock?
Immuneering Corporation Class A Common Stock trades under the ticker IMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immuneering Corporation Class A Common Stock stock going up?
IMRX has changed by -4.93% over the last week, -9.81% over the last month, and -36.51% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immuneering Corporation Class A Common Stock?
Immuneering Corporation Class A Common Stock currently has a market capitalization of 249.73 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immuneering Corporation Class A Common Stock earnings last quarter?
Last quarter, Immuneering Corporation Class A Common Stock reported earnings of -0.27 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immuneering Corporation Class A Common Stock net income for the last quarter?
Immuneering Corporation Class A Common Stock reported net income of -17.27 M for the last quarter. The previous quarter showed -13.46 M, which means net income changed by -28.30%.
How many employees does Immuneering Corporation Class A Common Stock have?
As of the latest available data, Immuneering Corporation Class A Common Stock has 57 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immuneering Corporation Class A Common Stock stock?
You can buy Immuneering Corporation Class A Common Stock (IMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immuneering Corporation Class A Common Stock stock?
Investing in Immuneering Corporation Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMRX chart and related analysis on metatrader.com as part of your research.